Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Obesity aggravates contact hypersensitivity reaction in mice

Majewska-Szczepanik, Monika, Kowalczyk, Paulina, Marcinska, Katarzyna, Strzepa, Anna, Lis, Grzegorz J., Wong, F. Susan ORCID: https://orcid.org/0000-0002-2812-8845, Szczepanik, Marian and Wen, Li 2022. Obesity aggravates contact hypersensitivity reaction in mice. Contact Dermatitis 87 (1) , pp. 28-39. 10.1111/cod.14088

[thumbnail of manuscript_Majewska-Szczepanik-resubmission with TNCB.pdf]
Preview
PDF - Accepted Post-Print Version
Download (405kB) | Preview

Abstract

Background Obesity is associated with chronic, low-grade inflammation in tissues and predisposes to various complications, including inflammatory skin diseases. However, the link between obesity and contact hypersensitivity (CHS) is not fully understood. Objectives We sought to determine the influence of obesity on T helper 1 (Th1)–mediated CHS. Methods The activity/phenotype/cytokine profile of the immune cells was tested in vivo and in vitro. Using quantitative polymerase chain reaction (qPCR) and fecal microbiota transplantation (FMT), we tested the role of a high-fat diet (HFD)–induced gut microbiota (GM) dysbiosis in increasing the effects of CHS. Results Exacerbated CHS correlates with an increased inflammation-inducing GM in obese mice. We showed a proinflammatory milieu in the subcutaneous adipose tissue of obese mice, accompanied by proinflammatory CD4+ T cells and dendritic cells in skin draining lymph nodes and spleen. Obese interleukin (IL)-17A−/−B6 mice are protected from CHS aggravation, suggesting the importance of IL-17A in CHS aggravation in obesity. Conclusions Obesity creates a milieu that induces more potent CHS-effector cells but does not have effects on already activated CHS-effector cells. IL-17A is essential for the pathogenesis of enhanced CHS during obesity. Our study provides novel knowledge about antigen-specific responses in obesity, which may help with the improvement of existing treatment and/or in designing novel treatment for obesity-associated skin disorders.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Wiley
ISSN: 0105-1873
Date of First Compliant Deposit: 6 February 2023
Date of Acceptance: 27 February 2022
Last Modified: 06 Nov 2023 18:50
URI: https://orca.cardiff.ac.uk/id/eprint/150363

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics